Related Experiment Video
Updated: Feb 17, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Abstract:
Preview Hypertension is a common target of cost-containment measures because so many people receive so much medication for it. However, to paraphrase Oscar Wilde's sentiments on being talked about: There is only one thing worse than the cost of treating hypertension, and that may be the cost of not treating hypertension. Dr Elliott describes some reasonable methods of cutting down on drug costs that do not result in insufficient or more costly medical care in the long term.
More Related Videos
04:37Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension V: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension II: Pathophysiology